| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
| Targets |
Human Endogenous Metabolite Microbial Metabolite
|
|---|---|
| References | |
| Additional Infomation |
IMP is a purine nucleoside 5'-monophosphate with inosine as its nucleobase. It is a human metabolite, an E. coli metabolite, and a mouse metabolite. It is a purine nucleoside 5'-monophosphate, and also an inosine phosphate. It is the conjugate acid of IMP(2-). Inosine 5'-monophosphate. Inosinic acid is a purine nucleotide with inosine as its base and a glycosyl group esterified with a phosphate group. Inosinic acid is present in or produced by E. coli (K12 strain, MG1655 strain). It has also been reported to be present in fruit flies, Arabidopsis thaliana, and other organisms with relevant data. Inosinic acid is a purine ribonucleotide with inosine as its base and a glycosyl group attached to a phosphate group. Inosinic acid and its salts are used as flavor enhancers in industrial food production. In vivo, inosine monophosphate participates in purine metabolism and serves as an intermediate in the synthesis of adenine and guanine, which are precursors to the second messenger signaling molecules adenosine monophosphate (AMP) and guanine monophosphate (GMP), respectively. Inosine monophosphate is a metabolite found or produced in Saccharomyces cerevisiae. Inosine 5'-monophosphate is a purine nucleotide with hypoxanthine as its base and a glycosidic acid group esterified with a phosphate group. See also: polyinosine monophosphate (monomer); polyinosine monophosphate-polycytidylic acid (high molecular weight) (monomer); polyinosine monophosphate-polycytidylic acid (low molecular weight) (monomer).
|
| Molecular Formula |
C10H13N4O8P
|
|---|---|
| Molecular Weight |
348.21
|
| Exact Mass |
348.047
|
| CAS # |
131-99-7
|
| Related CAS # |
Inosinic acid (disodium)(hydrate)(1:2:X);352195-40-5;Inosinic acid-13C10,15N4 dilithium;Inosinic acid-15N4 dilithium
|
| PubChem CID |
135398640
|
| Appearance |
White to off-white solid powder
|
| Density |
2.3±0.1 g/cm3
|
| Boiling Point |
793.7±70.0 °C at 760 mmHg
|
| Flash Point |
433.8±35.7 °C
|
| Vapour Pressure |
0.0±2.9 mmHg at 25°C
|
| Index of Refraction |
1.882
|
| LogP |
-1.1
|
| Hydrogen Bond Donor Count |
5
|
| Hydrogen Bond Acceptor Count |
10
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
23
|
| Complexity |
555
|
| Defined Atom Stereocenter Count |
4
|
| SMILES |
C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O
|
| InChi Key |
GRSZFWQUAKGDAV-KQYNXXCUSA-N
|
| InChi Code |
InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
|
| Chemical Name |
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O :~125 mg/mL (~358.98 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (143.59 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8718 mL | 14.3592 mL | 28.7183 mL | |
| 5 mM | 0.5744 mL | 2.8718 mL | 5.7437 mL | |
| 10 mM | 0.2872 mL | 1.4359 mL | 2.8718 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
